Featured Research

from universities, journals, and other organizations

Lengthier treatment for very preterm babies has not improved survival rates

Date:
April 21, 2010
Source:
BMJ-British Medical Journal
Summary:
Despite lengthier active resuscitation of very preterm babies over the past 15 years, their survival rates have not improved.

Despite lengthier active resuscitation of very preterm babies over the past 15 years, their survival rates have not improved, indicates research published ahead of print in the Fetal & Neonatal Edition of Archives of Disease in Childhood.

The authors base their findings on a case note review of babies born alive after 22 or 23 completed weeks of pregnancy between 1993 and 2007, in one region in the north of England.

During the study period, there were 480,662 live births, of which 229 babies were born at 22 or 23 weeks, a time point that is considered to be at the "margins of viability."

Two hundred and 10 of these babies died, one in three (34%) of whom lived for more than six hours. The length of time they lived gradually increased between 1993 and 2007.

The average survival of those who died, but were actively resuscitated, was 11 hours in 1993 to 1997, increasing to 20 hours in 1998-2002, and 3.7 days in 2003 to 2007.

In the last five years of the trends analysis, the accompanying documentation clearly showed the types of treatment given to these very premature babies.

Forty six out of 77 babies (60%) were actively resuscitated, 43 of whom survived for at least six hours. Ten of these babies underwent surgery.

These figures indicate that babies born at 22 to 23 weeks are increasingly being actively treated and for significantly longer in intensive care, but that the outcome is still the same, say the authors.

There was little evidence that more babies survived as time went on. Among the total of 19 survivors over the study period, six survived between 1993 and 1997; six survived between 1997 and 2002; and seven survived between 2003 and 2007.

The authors point out that survival rates for babies born at 24 weeks and above have increased, and that this may be why those born under 24 weeks are increasingly being actively treated as well.

Despite guidelines, the cut off point for providing active treatment for those born under 24 weeks remains "extremely contentious," they say, and parents push for treatment.

"Our local (anecdotal) experience is that most parents request an active approach immediately after delivery at 23 weeks' gestation, despite counselling from experienced clinicians using nationally consistent survival data," say the authors.


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Cite This Page:

BMJ-British Medical Journal. "Lengthier treatment for very preterm babies has not improved survival rates." ScienceDaily. ScienceDaily, 21 April 2010. <www.sciencedaily.com/releases/2010/04/100421191414.htm>.
BMJ-British Medical Journal. (2010, April 21). Lengthier treatment for very preterm babies has not improved survival rates. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/04/100421191414.htm
BMJ-British Medical Journal. "Lengthier treatment for very preterm babies has not improved survival rates." ScienceDaily. www.sciencedaily.com/releases/2010/04/100421191414.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins